Literature DB >> 21167209

Antiviral activity of ganciclovir and artesunate towards human cytomegalovirus in astrocytoma cells.

Nathalie Schnepf1, Jessie Corvo, Marie-José Sanson-Le Pors, Marie-Christine Mazeron.   

Abstract

Antimalarial drug artesunate inhibits cytomegalovirus (HCMV) replication in human fibroblasts. Astrocytes, the major cell type of the brain, support cytomegalovirus (HCMV) replication. The aim of the study was to assess the antiviral activity of artesunate in astrocytoma cell line U373MG in comparison with ganciclovir. The antiviral concentration inhibiting by 50% (IC(50)) the synthesis of viral DNA was measured by real-time PCR in parallel in U373MG and MRC-5 cells. Reference HCMV strains susceptible and resistant to ganciclovir, and clinical isolates were tested. Ganciclovir and artesunate had similar activity in U373MG cells and MRC-5 fibroblasts. The artesunate IC(50)s in U373MG cells (1.5-2.25 μM) were at least 36-fold lower than the 50% cytotoxicity concentrations. Then, the anti-HCMV activity of artesunate was demonstrated in a cancer cell line.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21167209     DOI: 10.1016/j.antiviral.2010.12.002

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  9 in total

1.  Antiviral effects of artesunate on JC polyomavirus replication in COS-7 cells.

Authors:  Biswa Nath Sharma; Manfred Marschall; Christine Hanssen Rinaldo
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

2.  Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation.

Authors:  Dana G Wolf; Avichai Shimoni; Igor B Resnick; Thomas Stamminger; Avidan U Neumann; Sunwen Chou; Thomas Efferth; Orit Caplan; Jessica Rose; Arnon Nagler; Manfred Marschall
Journal:  Antiviral Res       Date:  2011-04-03       Impact factor: 5.970

3.  An artesunate-containing antimalarial treatment regimen did not suppress cytomegalovirus viremia.

Authors:  Soren Gantt; Meei-Li Huang; Amalia Magaret; Lisa Bunts; Stacy Selke; Anna Wald; Philip J Rosenthal; Grant Dorsey; Corey Casper
Journal:  J Clin Virol       Date:  2013-07-01       Impact factor: 3.168

4.  Human embryonic lung fibroblasts treated with artesunate exhibit reduced rates of proliferation and human cytomegalovirus infection in vitro.

Authors:  Ai-Hong Zeng; Yang-Ying Ou; Ming-Ming Guo; Xuan Dai; De-Zhi Zhou; Rui Chen
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

5.  Antiviral effects of artesunate on polyomavirus BK replication in primary human kidney cells.

Authors:  Biswa Nath Sharma; Manfred Marschall; Stian Henriksen; Christine Hanssen Rinaldo
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

6.  The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.

Authors:  E Oiknine-Djian; Y Weisblum; A Panet; H N Wong; R K Haynes; D G Wolf
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 7.  The Use of Antimalarial Drugs against Viral Infection.

Authors:  Sarah D'Alessandro; Diletta Scaccabarozzi; Lucia Signorini; Federica Perego; Denise P Ilboudo; Pasquale Ferrante; Serena Delbue
Journal:  Microorganisms       Date:  2020-01-08

8.  Artesunate and Dihydroartemisinin Inhibit Rabies Virus Replication.

Authors:  Jun Luo; Yue Zhang; Yang Wang; Qing Liu; Jiesen Li; Hongling He; Yongwen Luo; Shile Huang; Xiaofeng Guo
Journal:  Virol Sin       Date:  2021-03-04       Impact factor: 4.327

Review 9.  Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function.

Authors:  Catherine S Adamson; Michael M Nevels
Journal:  Viruses       Date:  2020-01-16       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.